Welcome to our dedicated page for Sharps Technology SEC filings (Ticker: STSSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sharps Technology Inc. filings document regulatory disclosures for a Nevada operating company with medical device sales and distribution activities and a Solana-focused digital asset treasury strategy. Current reports describe material agreements, at-the-market equity offering arrangements, executive officer appointments, indemnification agreements, committee changes, and capital-structure matters involving common stock and warrants.
Proxy statements disclose stockholder voting matters, including director elections, auditor ratification, equity incentive plan approvals, and authorization for warrant-related share issuances. The filing record also covers governance procedures, Nasdaq rule considerations, registration-statement use, and securities offering mechanics tied to the company’s common stock and warrant structure.
Sharps Technology Inc. (STSS/STSSW) director Timothy James Ruemler reported four separate sales of company common stock on 08/27/2025, each for 5,000 shares at prices of $16.575, $16.54, $17.0922 and $16.75. After these transactions his beneficial ownership fell from 35,218 shares to 20,218 shares as shown on the form. The filing includes an explanatory note stating the shares were sold inadvertently and that Mr. Ruemler has tendered $90,600 to the company to cover short-swing profits. The Form 4 is signed and dated 08/28/2025.
Sharps Technology Inc. director Timothy Ruemler reported a series of open-market purchases totaling 40,000 shares of common stock on August 25, 2025, at prices ranging from $9.60 to $12.50, bringing his directly held stake to 40,218 shares.
He also received an option to buy 80,000 additional shares at an exercise price of $6.41 per share, granted under the company’s 2025 Equity Incentive Plan. This option becomes fully vested and exercisable on May 22, 2026 and expires on August 22, 2035.
Jason L. Monroe, a director of Sharps Technology Inc. (STSS), was granted an option to purchase 80,000 shares on 08/22/2025 with an exercise price of $6.41 per share. The option was granted under the company’s 2025 Equity Incentive Plan and will become 100% vested and exercisable on May 22, 2026. The Form 4 was signed by Mr. Monroe on 08/26/2025.
Andrew R. Crescenzo, who serves as Chief Financial Officer and a director of Sharps Technology Inc., was granted an option to purchase 40,000 shares on 08/22/2025 at an exercise price of $6.41 per share under the company's 2025 Equity Incentive Plan. The option is shown as directly beneficially owned for 40,000 shares following the grant and will become 100% vested and exercisable on May 22, 2026. The Form 4 was signed by Mr. Crescenzo on 08/26/2025. The filing lists the issuer as Sharps Technology Inc. (STSS).
Robert M. Hayes, a director of Sharps Technology Inc. (ticker shown as STSS), reported a securities transaction on a Form 4. The filing records an option (right to buy) for 100,000 shares with a price of $6.41. The transaction line shows the option entry dated 08/22/2025 and indicates the shares were acquired (code A) and are held directly. The filing notes the grant was made under the Company’s 2025 Equity Incentive Plan and that the option will be 100% vested as of the issuance date. The form includes an earliest-transaction date of 12/04/2024 and a signature dated 08/26/2025.
The reporting person, Soren Bo Christiansen, a director of Sharps Technology Inc. (STSS), was granted an option to purchase 80,000 shares on 08/22/2025 at an exercise price of $6.41 per share under the company's 2025 Equity Incentive Plan. The option will become 100% vested and exercisable on May 22, 2026. Following the grant the reporting person beneficially owns 80,000 shares/options as reported.
Paul K. Danner, a director of Sharps Technology Inc. (STSS), was granted options to purchase 400,000 shares at an exercise price of $6.41 per share. The grant was reported with a transaction date of 08/22/2025 and the option is scheduled to become 100% vested and exercisable on May 22, 2026. Following the reported transaction, Mr. Danner beneficially owns 400,000 shares subject to the option on a direct basis. The grant was made pursuant to the company's 2025 Equity Incentive Plan.
Brenda Baird Simpson, a director of Sharps Technology Inc. (ticker: STSSW), was granted a non‑derivative option to purchase 20,000 shares on 08/22/2025 at an exercise price of $6.41 per share. The option was granted under the company’s 2025 Equity Incentive Plan and "will become 100% vested as of the date of issuance," per the filing. Following the grant, Ms. Simpson directly beneficially owns 20,000 shares/options reported on this Form 4.
Sharps Technology, Inc. entered into cash and cryptocurrency private placement agreements to sell common stock, pre-funded warrants and stapled warrants, targeting estimated aggregate gross proceeds of about $400 million before fees to implement a Solana-focused treasury strategy. Cash investors will pay in U.S. dollars or stablecoins, while cryptocurrency investors will pay in SOL tokens, with related warrants generally exercisable at $0.0001 for pre-funded shares and $9.75 for stapled warrants, subject in part to stockholder approval.
The company plans to use proceeds to buy SOL via open-market purchases, build Solana treasury operations, and for general corporate purposes, held in a separate account. Authorized common shares were increased from 1,666,667 to 500,000,000, significantly expanding potential issuance capacity. Existing Series A warrants for 347,774 shares had their exercise price cut from $87.60 to $6.50.
Leadership changed as CEO and director Robert M. Hayes resigned, receiving a $1.2 million lump-sum payment, extended benefits and fully vested options for 100,000 shares. Paul K. Danner became Executive Chairman and Principal Executive Officer with a $600,000 annual salary, and Yuwen (Alice) Zhang was appointed Chief Investment Officer and director, also with a $600,000 base salary. The company signed a settlement term sheet over prior litigation that could materially affect its financial position if the offering is not completed, and a non-binding LOI under which the Solana Foundation may sell $50 million of SOL to the company at a 15% discount following a public offering.
Sharps Technology, Inc. is registering 2,000,000 common shares on Form S-8 for issuance under its 2025 Equity Incentive Plan.
The plan is designed to provide compensation, enticement, and incentive awards, allowing the company to grant equity-based awards to eligible participants. The filing also outlines Nevada law and corporate provisions that allow the company to indemnify its directors, officers, employees, and agents in certain circumstances, and notes that Sharps maintains directors’ and officers’ liability insurance. Standard undertakings confirm that future SEC reports will update this registration by reference.